GSMDE 2020 satellite symposium [Key takeaways]: Beyond movement disorders and epilepsy: Understanding aromatic L-amino acid decarboxylase (AADC) deficiency
View the key takeaways from our
GSMDE 2020 symposium, which summarizes the characteristic features, diagnosis, and management of AADC deficiency. Review the key clinical features of AADC deficiency which may help to distinguish the condition from epilepsy The clinical presentation of AADC deficiency, including symptoms that overlap with epilepsy and core diagnostic tests for achieving a confirmational diagnosis, are discussed
This is a summary of a symposium hosted by PTC Therapeutics at the 2020 GSDME Annual Meeting in Barcelona, Spain; it was organized and funded by PTC Therapeutics.
Register now to unlock the content
Register now to access the content on this page
If not, register below
GL-AADC-0703 | June 2021
Close Register here to access the content on the site GL-CORP-0207 | June 2021
You are now leaving MEDhub, a website provided by PTC Therapeutics. This link will take you to a website to which our
Privacy Statement and our Terms and Conditions do not apply.
GL-CORP-0207 | June 2021
Close COMING SOON
The content you are trying to access is not currently available.
We will be updating the MEDhub site regularly to provide you with up-to-date, insightful expert-led content. To be notified when new additions become available,